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Objective: The effect of suprarenal stent fixation during endovascular aortic aneurysm repair (EVAR) on renal function
remains unclear. A unique validated three-dimensional intraluminal imaging technique was used to analyze the effect of
suprarenal stent position relative to renal artery orifices. Also analyzed was its medium-term to long-term effects on renal
function.
Methods: The study cohort comprised 29 of 34 consecutive patients who underwent EVAR with the Zenith endograft
system from September 1999 to March 2002 at a single institution. The precise locations of the uncovered suprarenal
stent struts were assessed by a virtual endoscopic imaging technique. Anatomic and quantitative categorization of patients
was made according to the configuration of uncovered stent struts across the renal artery ostia (RAO). The anatomic
subgroups were defined as struts located centrally or peripherally across both RAO. The quantitative subgroups were
defined as RAO crossed by multiple struts, a solitary strut, or no struts. The subgroups were compared for their renal
function, as assessed by temporal measurements of serum creatinine concentration and creatinine clearance, and renal
parenchymal perfusion defects, as assessed using contrast-enhanced computed tomography (CT).
Results: Mean follow-up was 52.7 months. Separate subgroup analysis for both anatomic and quantitative configurations
did not demonstrate any significant difference in renal function between the different strut permutations (P > .05).
Follow-up imaging confirmed one case of renal infarction secondary to an occluded accessory renal artery, although this
patient had normal serum creatinine levels.
Conclusion: RAO coverage by suprarenal uncovered stents does not appear to have a significant effect on renal function
as evaluated by creatinine measurements in patients with normal preoperative renal function. (J Vasc Surg 2007;45:
694-700.)Increasingly, suprarenal stent fixation is the preferred
method of proximal endograft fixation in endovascular
aneurysm repair (EVAR), especially when the proximal
neck anatomy is less favorable because of short neck, angu-
lation, conicity, thrombus, or calcification.1-2 Although
renal dysfunction or failure as a direct consequence of
suprarenal stent strut positioning across the renal artery has
yet to be reported, longer-term renal effects of this tech-
nique are still unknown.3
It is postulated that renal dysfunction, when present
after suprarenal stent fixation, is a multifactorial process. It
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694is not clear whether the proximal position of the stent struts
across the renal artery ostia (RAO) causes an occlusive
process that impairs blood flow or whether disruption of
aortic thrombus and plaques from endovascular manipula-
tions during device positioning and deployment causes
microembolization that could potentially cause renal per-
fusion defects or infarcts.4 Neointimal hyperplasia around
the stent may also exacerbate the occlusive process.5
The purpose of this study was to determine the medium-
term to long-term effects on renal function of suprarenal
stent fixation during EVAR in patients with normal preop-
erative renal function.
MATERIALS AND METHODS
Patient selection. Consecutive patients undergoing
elective EVAR between September 1999 and March 2002
at a single institution were prospectively studied. Endovas-
cular repair was offered to patients with suitable abdominal
aortic aneurysm (AAA) anatomy who were high risk for
open repair.6 Patients with a history of renal impairment or
a preoperative serum creatinine level 130 mmol/L were
excluded.7
The endograft used in this study was a standard preor-
dered bifurcated endoluminal prosthesis based on the
JOURNAL OF VASCULAR SURGERY
Volume 45, Number 4 O’Donnell et al 695Zenith system (William Cook Europe ApS, Bjaeverskov,
Denmark). A self-expanding modular bifurcated aortic en-
dograft with uncovered 2.5-cm-long suprarenal struts (Fig 1)
for proximal fixation around the level of the renal arteries
was placed using the standard transfemoral approach.8 All
operations were performed by vascular surgeons and inter-
ventional radiologists who were proficient in EVAR.
Baseline demographic data, medical comorbidities, and
risk factors were obtained for all patients. Serum creatinine
concentration, aneurysm size, morphologic data, and the
presence of any renal parenchymal perfusion defects were
recorded both preoperatively and at each follow-up assess-
ment. All postoperative sequelae, including any significant
medical problems, were documented.
Assessment of renal function. Renal function was
assessed by temporal measurements of serum creatinine
(SCr) throughout the perioperative period and at subse-
quent outpatient reviews. Creatinine clearance was esti-
mated using the Cockcroft-Gault formula9: Creatinine
clearance  [(140 – age)  weight]/(SCr  72) for men
and [(140 – age)  weight]/(SCr  85) for women.
Computed tomography assessment. Helical CT
scans were obtained with a single-slice Philips AV-E1CT
scanner (Philips Medical Systems, Eindhoven, The Nether-
lands) as per unit protocol (collimation, 5 mm; pitch, 1.0;
reconstruction interval, 2 mm). Intravenous contrast me-
dium (Omnipaque 300, Sandofi-Winthrop, New York,
NY) was administered as a single uniphasic power injection
at a rate of 2 to 3mL/s to a total of 100mL and a scan delay
of 30 seconds. CT scans were completed on each patient
preoperatively and postoperatively at 1 week, at 1, 3, 6, and
12 months, and annually thereafter.
A Toshiba 16 multislice CT scanner (Medical Imaging
Systems, Kingsbury, UK) was installed in the Department
of Radiology in 2004 and was used for CT scans later in the
follow-up period. The scanning protocol for 16-slice CT
was section thickness, 1.0 mm; pitch, 2.0; and a reconstruc-
tion interval of 1.0 mm.
The follow-up CT angiograms were used to determine
Fig 1. Zenith self-expandingmodular bifurcated aortic endograft
with magnified view of the uncovered suprarenal stent struts.maximal aneurysmal sac diameter, identify the presence ofendoleaks or stent migration, confirm the patency of the
stent graft and renal arteries, and also to detect the presence
of any renal parenchymal perfusion defects.
Assessment of stent struts in relation to renal artery
ostia morphology. A novel, locally developed technique,
virtual intravascular endoscopy (VIE), was used to assess
the precise location of the uncovered suprarenal stent
struts. All patients were given an intravenous contrast en-
hancement with a total volume of 100 mL administered at
an injection rate of 2 mL/s and a scan delay of 30 seconds.
Helical CT angiography was performed before and after
stent grafting at a single-slice CT scanner with the scanning
protocol of collimation, 5 mm; pitch, 1.0; and reconstruc-
tion interval, 2 mm. Poststent grafting CT angiography
data sets were acquired within 1-week after stent graft
implantation.
Virtual endoscopic images of the renal ostia and aortic
stent struts were postprocessed in a workstation equipped
with the commercial software Analyze 4.0 (Mayo Clinic,
Rochester, Minn, or www.AnalyzeDirect.com). Genera-
tion of VIE images was subsequently determined by using
a CT number thresholding technique. A CT number
range was applied to generate optimal VIE images with
fewer artifacts, which was identified by measuring the
region of interest in the level of the renal arteries. The
threshold range was measured in each patient because
the degree of contrast enhancement differed with each
individual (Fig 2).10
The VIE allowed the precise intraluminal position of
the metal struts in relation to the aortic ostia to be assessed
(Fig 3). This technique has been previously validated using
both stent graft phantommodels in vitro and in vivo patient
studies.11-13 Anatomic and quantitative categorization of
patients was made according to the configuration of uncov-
Fig 2. Helical computed tomography angiography formatted for
three-dimensional postprocessing shows (a) intraluminal thresh-
old view, (b) metallic stent threshold view, and (c) combined
image demonstrating the stent strut crossing the luminal ostia.ered stent struts across the RAO. The anatomic subgroup
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peripherally across both RAO. The quantitative subgroup
was defined as patients with RAO crossed by multiple
struts, a solitary strut, or no struts.
Statistical analysis. Normal distribution for study pa-
rameters was confirmed by histogram andQ-Q distribution
plotting. Separate statistical analysis for anatomic and quan-
titative subgroups using analysis of variance for linear trend
Fig 3. Virtual intravascular imaging. A, Peripheral encroachment
of the renal artery ostia (stent struts shown by black arrows). B, No
encroachment of the renal artery ostia (clear ostia shown by white
arrows).in both serum creatinine concentration and creatinineclearance was performed with SPSS 13 statistical software
(SPSS Inc, Chicago, Ill). A paired sample t test was used to
assess the creatinine trends and aneurysm size at separate
postoperative time points compared with the preoperative
baseline. All tests were two-tailed, with P .05 considered
significant.
RESULTS
Demographics. During the study period, 34 consec-
utive patients underwent EVAR. Five patients were ex-
cluded: four because of raised preoperative serum creati-
nine levels (1 with dialysis-dependant chronic renal failure,
1 with previous left nephrectomy for renal dysgenesis, 2
with moderate renal impairment), and one at 12 months
because dialysis-dependant renal failure developed second-
ary to perforated sigmoid diverticular disease. Six women
and 23 men were studied. The Table summarizes patient
demographics and operative and postoperative clinical
data.
Renal function. No episodes of acute renal failure
occurred in the perioperative period. The VIE findings
were used to categorize the stent struts in each of the 29
patients into two separate groups according to (1) the exact
Table. Patient demographics and operative and
postoperative clinical data
Men (n  23) Women (n  6)
Preoperative
Mean age, years
(95% CI) 73.0 (69.7-76.3) 75.7 (68.9-82.5)















(95% CI) 67.8 (62.5-73.2) 60.7 (54.8-66.6)
Operative
Operative time (min) 194 155
Transfused blood (mL) 961 1375
Contrast infused (mL) 303 320
Blood loss (mL) 350 300
Postoperative
Time in ICU (days) 0.4 0
Time to discharge (days) 11.1 8.7
Follow-up, months
(range) 53.9 (6.6-79.6) 48.0 (13.5-77.6)
Alive 16 2
CI, Confidence interval; ASA, American Society of Anesthesiologists; MI,
myocardial infarction;COPD, chronic obstructive pulmonary disease;AAA,
abdominal aortic aneurysm; ICU, intensive care unit.anatomic location and (2) the number of stent struts across
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serum creatinine concentration between different strut per-
mutations for both these anatomic and quantitative config-
urations did not demonstrate any statistical significance
(P  .05; Fig 4, Fig 5).Estimated creatinine clearance9
remained consistent with the serum creatinine levels and
demonstrated no statistical difference between the different
strut permutations.
Although there did not appear to be a significant dif-
ference in serum creatinine levels between the different
stent strut groups, an overall trend of increasing creatinine
levels, followed by improvement, was demonstrated over
time when all patients were analyzed together as a group
(2.2 mmol/L maximal perioperative level, 10.1
mmol/L at 24 months, and4.6 mmol/L at 36 months).
This trend did not reach statistical significance (P  .15),
however.
Computed tomography assessment. Preoperative
CT imaging revealed two patients with accessory renal
arteries. After EVAR, one of these patients sustained an
infarct to the medial aspect of the lower pole of the left
kidney, which was identified on the 1-week postoperative
scan. Although a solitary central stent strut was identified
across this patient’s RAOonVIE, the infarct appeared to be
Fig 4. Analysis variance test for linear trend in serum creatinine
concentration (mmol/L) for the anatomic configuration subgroup
(presence of centrally located struts around one, both, or none of
the renal artery ostia).
Fig 5. Analysis variance test for linear trend in serum creatinine
concentration (mmol/L) for the quantitative configuration sub-
group (quantity of struts present at either of the renal artery ostia).secondary to an occlusion of a small accessory renal artery.The other patient had an intact accessory renal artery and
had no identifiable renal impairment on the CT scan. VIE
confirmed the presence of a solitary peripheral stent strut
across the RAO on that side. Both patients retained normal
biochemical renal function in the postoperative period. VIE
and CT follow-up imaging found no evidence of primary
renal artery occlusion in any of the patients.
A type I endoleak was identified in one patient after a
technically difficult procedure owing to poor quality of the
infrarenal neck and an unusually wide origin of the left renal
artery. This patient, unfortunately, died 13 months post-
EVAR from hemorrhage caused by rupture secondary to
this persisting endoleak, despite two subsequent therapeu-
tic interventions including the placement of further covered
extension (Cook) and Palmaz (Cordis Endovascular, War-
ren, NJ) fixation stents.
Five patients with type II endoleaks were identified
postoperatively. Three patients had stable AAA size and
were managed conservatively. Two patients had AAA ex-
pansion, and the endoleaks were treated with inferior mes-
enteric artery (IMA) coiling and thrombin-injection embo-
lization, respectively. These endoleaks have persisted but
remained stable, without any increase in AAA size on
surveillance CT scans.
Two type III endoleaks were also identified. One pa-
tient had an endoleak identified at the proximal end of the
first covered portion of the graft, which was thought to
represent a type III endoleak arising from a tear in the
endograft fabric rather than a type I endoleak. This was
subsequently treated with the placement of a Zenith aor-
touniiliac system, and in one patient with a pre-existing
type II endoleak, a dislocation developed at the left iliac
limb that was treated successfully with the insertion of a
limb extension.
As expected, there was a statistically significant reduc-
tion in maximal aneurysmal sac diameters over time com-
pared with the preoperative baseline for all patients when
analyzed together: –7.3% at 6 months, –15.6% at 12
months, –12.3% at 24 months, –24.0% at 36 months, and
–18.7% at 48 months (P  .05).
Outcomes. Follow-up continued until March 2006
(mean, 52.7 months; range, 6.6 to 79.6 months) and was
100% complete for each patient. Eighteen patients (16
men, 2 women) remain well. Four patients died from
cancer related illnesses (2 patients within the 12-month
postoperative period), three from ischemic heart disease,
and one from end-stage respiratory disease. Only one
procedural-related death occurred, as documented previ-
ously, from a persisting type I endoleak. We were unable to
trace the cause of death in the other two patients.
DISCUSSION
Suprarenal endograft fixation is increasingly common
in EVAR, especially in patients who have suboptimal prox-
imal aortic neck anatomy. Although early results are en-
couraging,14-21 the long-term effect of the placement of
uncovered stent struts across the RAO remains unclear.
Renal artery stenosis, inadvertent coverage of the renal
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creatinine levels, and renal failure have all been reported
after EVAR with suprarenal fixation.14-22 The exact cause
of the renal impairment that presents after EVAR remains
obscure, however. Various mechanisms have been sug-
gested, but a combination of factors is most likely respon-
sible.
Patients presenting for AAA surgery are often elderly,
with multiple cardiovascular comorbidities such as ischemic
heart disease, renovascular occlusive disease, or diabetes.
Medical management of these conditions often requires a
multitude of pharmacologic agents that may further com-
promise renal function. Progression of the atherosclerotic
process may also predispose the patient to renal dysfunc-
tion. Tiao et al23 reported an increase in creatinine levels,
especially in the vascular age group of 60 to 80 years, and
documented that after the age of 75 years, patients lose
about 2% of creatinine clearance per year.
Contrary to a normal physiologic process, proponents
of endovascular repairs for AAA have postulated various
mechanisms that could account for renal dysfunction dur-
ing the intraoperative and follow-up periods after EVAR.
Thromboembolism during manipulation and placement of
the endograft within the aortic neck and aneurysm sac
caused by disruption of mural atheroma or thrombus may
result in microembolization to the renal arteries. Kramer
et al19 suggested an atheroembolic etiology after the iden-
tification of punctate renal infarcts on follow-up CT scans.
The incidence of microembolization was also higher in
patients undergoing EVAR compared with conventional
open surgery.4 With modern endovascular grafting sys-
tems, however, procedural related manipulation is mini-
mized, and therefore, a reduction in the disruption of
thrombus should lead to a lower incidence of renal micro-
embolism and subsequent functional impairment.
Contrast-induced nephrotoxicity during the procedure
itself and follow-up CT surveillance has also been associ-
ated with an increased serum creatinine level.24,25 This
deleterious effect may, however, be more significant in the
short-term owing to a higher frequency of contrast-
enhanced radiologic imaging. Greenberg et al25 demon-
strated an initial deterioration in renal function that stabi-
lized at 12 months, followed by an improvement at 24
months. Our study concurred, with a maximal deteriora-
tion in renal function at 24 months, followed by an im-
provement at 36 months.
Considerable debate surrounds the potential occlusive
effect of suprarenal stent struts across the RAO andwhether
this itself predisposes the patient to renal dysfunction or
acts as an accelerant of the atherosclerotic process:
● Bove et al17 reported a progression of renal artery
stenosis from 30% to 60% 12 months after endograft-
ing in one of eight patients with preoperative evidence
of renal artery atherosclerotic disease and in another
patient with normal preoperative renal arteries who
developed 60% stenosis 1 month postoperatively.● Lobato et al16 reported similar findings in one of five
patients with pre-existing unilateral renal artery steno-
sis which progressed from60% to 99% 4months after
suprarenal fixation.
● Lau et al22 reported that renal artery occlusion devel-
oped in two patients with pre-existing renal artery
stenosis 50%.
● Marin et al,15 in contrast, reported an absence of
disease progression after suprarenal endograft fixation
in 18 patients with pre-existing significant renal artery
stenosis.
Various imaging methods had been used to assess the
renal arteries in these studies. Using VIE, a novel and more
precise technique of revealing intraluminal encroachment
of the RAO, we demonstrated that suprarenal endograft
fixation does not produce significant renal artery occlusion
or impair physiologic function as measured by serum cre-
atinine concentration in patients with normal preoperative
renal function.
The role of different stent types in the development of
renal artery occlusion has also been reported. Birch et al26
demonstrated a stent-dependant partial RAO occlusion
secondary to the development of disorganized acellular
matrix; however, these findings are based on a porcine
model, and human ramifications are not yet clear. One
study reported that approximately 15% to 30% of all adult
patients have accessory renal arteries.27 We report a preva-
lence of 6.9% (2/29 patients) in this study. Although one
of these patients sustained a renal parenchymal infarct,
there was no evidence of any abnormal biochemical se-
quelae. Karmacharya et al28 report that the sacrifice of these
accessory vessels does not necessarily lead to a detectable
renal infarction, and even if it occurs, the insult seems to
be well tolerated.
We do acknowledge various limitations. The 29 pa-
tients who were fully analyzed in this study only represent a
small cohort of our endovascular experience (237 EVAR
procedures to date). Although serum creatinine concentra-
tion is widely used as an indicator of renal function, it is not
the most sensitive method for detecting renal dysfunction
in patients. We recognize that renal artery stenosis, signifi-
cant renal parenchymal tissue loss, and impaired glomerular
filtration rate can be present before biochemical abnormal-
ities are detected. Factors such as muscle mass and protein
intake can also influence serum creatinine.29-30
An estimation of creatinine clearance using the
Cockcroft-Gault formula9 was also used to account for the
age, gender, and weight variations. This did not demon-
strate any statistical significance between stent strut config-
urations.
The gold standard for monitoring renal function is the
measurement of glomerular filtration rate (GFR); however,
patient compliance for GFR is often poor. Serum cystatin C
as a more accurate marker of GFR is well documented and
may be appropriate for further studies because its concen-
tration is not influenced by infections, liver diseases, or
inflammatory diseases.31 It is also a more practical method
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nience of a 24-hour collection of urine.32
Although axial CT scanning is optimal for assessing
aneurysm morphology and the presence of complications
such as endoleaks, pseudoaneurysm formation, and even
incidental pathologies, it may not be ideal for evaluation of
renal artery anatomy and patency after EVAR. Several other
methods for evaluation of renal artery stenosis may be
appropriate as an adjunct in patient assessment, such as
renal artery duplex ultrasonography,5 magnetic resonance
angiography, and percutaneous angiography. However,
unlike VIE, none of these methods are able to precisely
identify the position of the stent struts across the RAO.
We also acknowledge that the initial CT scans were
performed with a single-slice CT scanner, which resulted in
suboptimal spatial resolution. This was the only available
CT scanner within the Department of Radiology at that
time. We did, however, validate the imaging quality of the
single-slice CT scanner against a phantom plastic model
aorta with a Zenith endograft deployed within the lu-
men.11 This study confirmed the reliability of even the
single-slice scanner in the localization of the stent struts.
Scans performed with multislice CT (16 detector rows)
are preferable to produce images with higher spatial reso-
lution and better contrast enhancement in the abdominal
aorta, which is especially useful for generation of three-
dimensional images including VIE visualization.33
Another limitation was the fixed scan delay used in our
study. The automatic bolus tracking technique to maxi-
mize contrast enhancement in the arterial segments has
become widely available in clinical practice, and this would
be appropriate for future follow-up imaging.
Finally, we did not perform quantitative measurement
of the cross-sectional area reduction of RAO by stent struts
because our previous experience showed that VIE tends to
overestimate the diameter of the stent struts across the
RAO.3 Also, other published in vitro studies have demon-
strated no significant effect of stent struts on the renal artery
in terms of interference with blood flow or reduction of
cross-sectional area.34
CONCLUSION
This study demonstrates new insight into the anatomic
position of the suprarenal stents across the RAO and their
subsequent effects on renal function after EVAR surgery.
VIE itself will probably not be warranted for preoperative
imaging or diagnostics compared with axial CT images.13
However, the ability to provide high quality information on
the three-dimensional relationship of the suprarenal stent
struts to the aortic branch ostia is of interest in the
follow-up of EVAR patients. Although VIE has already
been widely described,3,11-13 this is the first report, to our
knowledge, of the use of VIE imaging and its relationship
to suprarenal stenting and renal function in the medium-
term to long-term.
After review of themultiple permutations of stent struts
based on the anatomic and quantitative configurations of
struts at the ostia, we conclude that the RAO coverage bysuprarenal uncovered stents does not appear to have a
significant effect on renal function as evaluated by creati-
nine measurements in patients with normal pre-operative
renal function. Further evaluation of the use of VIE to
assess the effects of stent migration and changes in strut
morphology at the RAO over time in these patients is
warranted.
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